உறுப்பினர் ஜேம்ஸ் வந்தவர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from உறுப்பினர் ஜேம்ஸ் வந்தவர். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In உறுப்பினர் ஜேம்ஸ் வந்தவர் Today - Breaking & Trending Today

House Bill Would Create Long-Awaited Software and Data Roles at Federal Agencies


House Bill Would Create Long-Awaited Software and Data Roles at Federal Agencies
Vertigo3d/iStock.com
email
The proposal would create new positions, including software development, software engineering and data scientists.
The federal government would finally be able to hire specifically for “software development,” “software engineering,” “data management,” and “knowledge management” positions under new legislation before the House.
Over multiple administrations, the federal government has tried to get better at hiring and retaining tech-savvy employees but continues to meet challenges, including the lack of specific job roles for positions that are critical to creating a digitally-driven government.
The Federal Career Opportunities in Computer Science Work Act looks to remedy that for four such positions. The bill introduced by Reps. Jay Obernolte, R-Calif., and Peter Welch, D-Vt. would give the Office of Personnel Mana ....

Carolyn Maloney , Suzette Kent , Peter Welch , Jay Obernolte , Office Of Personnel Management , House Committee On Oversight , National Security Commission On Artificial Intelligence , Federal Career Opportunities , Computer Science Work Act , Personnel Management , House Committee , Federal Data Strategy , Evidence Based Policymaking Act , Evidence Act , National Security Commission , Artificial Intelligence , Member James Comer , Open Government Data Act , கரோலின் மலோநீ , சூஜேட்டே கேண்ட் , பீட்டர் வெல்ச் , அலுவலகம் ஆஃப் பணியாளர்கள் மேலாண்மை , வீடு குழு ஆன் ஓவர்‌ஸைட் , தேசிய பாதுகாப்பு தரகு ஆன் செயற்கை உளவுத்துறை , பணியாளர்கள் மேலாண்மை , வீடு குழு ,

Congress Slams AbbVie Over Price Hikes, 'Frivolous' Patents


email article
House lawmakers on both sides of the aisle pummeled AbbVie CEO Richard Gonzalez for raising the price of two widely used drugs and for the company s legally questionable tactics to head off competition from biosimilars, despite pulling in healthy profits.
Much of Tuesday s House Committee on Oversight and Reform hearing centered around two issues: the risks and benefits of Medicare price negotiation and potential abuse of the patent system.
Committee Chairwoman Carolyn Maloney (D-N.Y.) charged that Gonzalez and other AbbVie executives were actively targeting the U.S. for price increases while lowering prices in other countries.
AbbVie charges $77,000 for a year s supply of adalimumab (Humira), which is 470% more than what it charged when the drug was first launched in 2003. A single syringe of the tumor necrosis factor (TNF) blocking agent costs over $1,000 more in the U.S. compared to some other countries, including Canada, Japan, Korea, an ....

United States , Richard Gonzalez , Tahir Amin , Carolyn Maloney , Shannon Firth , Aaron Kesselheim , Elijah Cummings , Elijahe Cummings , Much Of Tuesday House Committee On Oversight , Initiative For Medicines , Trademark Office , Republican Committee , Harvard Medical School , House Committee , Chairwoman Carolyn Maloney , Lower Drug Costs Now Act , Chairman Elijah Cummings , Member James Comer , More Cures Act , Clay Higgins , Too Many , Medpage Today , Investigative Reporting , ஒன்றுபட்டது மாநிலங்களில் , ரிச்சர்ட் கோன்சலஸ் , தாஹிர் அமின் ,